Search
Aluminum chlorohydrate
go.drugbank.com/drugs/DB11573ApprovedAluminum chlorohydrate is a group of water-soluble aluminum complexes with the general formula AlnCl(3n-m)(OH)m. It is included up to 25% in over-the-counter hygiene products as an active antiperspirant agent. The primary site of action ...
Products: Far Away Dreams Roll-On Antiperspirant Deoderant, Far Away Roll-On Anti-Perspirant DeodorantCopper
go.drugbank.com/drugs/DB09130ApprovedInvestigationalIt is important to the function of many enzymes including cytochrome c oxidase, monoamine oxidase and superoxide dismutase [FDA Label].
Mixtures: O-Cal FA multivitamin, O-Cal FA multivitaminDelafloxacin
go.drugbank.com/drugs/DB11943ApprovedInvestigationalDelafloxacin is a fluoroquinolone antibiotic which has been used in trials studying the treatment and basic science of Gonorrhea, Hepatic Impairment, Bacterial Skin Diseases, Skin Structure Infections, and Community Acquired Pneumonia, a...
Rotavirus vaccine
go.drugbank.com/drugs/DB10276ApprovedInvestigationalRotavirus commonly infects children and infants causing severe diarrhea and vomiting leading to potentially fatal dehydration. Two rotavirus vaccines are available for the prevention of rotavirus gastroenteritis, Rotateq and Rotarix. Rot...
Azithromycin
go.drugbank.com/drugs/DB00207ApprovedInvestigationalIt was initially approved by the FDA in 1991 [A174175].
Products: Nra-azithromycinBenzalkonium
go.drugbank.com/drugs/DB11105ApprovedInvestigationalBenzalkonium is more commonly contained in consumer products in its salt form, benzalkonium chloride [FDA Label]. … Benzalkonium is a quaternary ammonium compound used as a biocide, a cationic surfactant, and as a phase transfer agent [FDA Label].
Mixtures: ORA-SED JELProducts: Rast A Fri Stank Off Odor Eliminator Rose, Rast A Fri Stank Off Odor Eliminator LavenderCatumaxomab
go.drugbank.com/drugs/DB06607ApprovedWithdrawnCatumaxumab was approved for market in Canada in May 2012 for the same condition [FDA Label]. It is currently available under the brand name Removab.
Sarilumab
go.drugbank.com/drugs/DB11767ApprovedInvestigationalarthritis (RA) in combination with methotrexate. … [A27262] Sarilumab was developed by Sanofi and Regeneron Pharmaceuticals, Inc; it was US FDA-approved in May 2017 and followed by EU approval in June 2017 for the treatment of moderate to severe rheumatoid
Brexanolone
go.drugbank.com/drugs/DB11859ApprovedInvestigationalAs of March 2019, brexanolone - developed and made available commercially by Sage Therapeutics Inc. as the brand name product Zulresso - is the first drug to have ever been approved by the US FDA specifically
Paritaprevir
go.drugbank.com/drugs/DB09297ApprovedInvestigationalWithin Canada and the United States, paritaprevir is currently available in three fixed dose products: Viekira Pak (FDA), Technivie (FDA and Health Canada), and Holkira Pak (Health Canada). … More specifically, paritaprevir prevents viral replication by inhibiting the NS3/4A serine protease of Hepatitis C Virus (HCV) [FDA Label].